Overview

A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients

Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
This study evaluated two doses of tenofovir alafenamide versus tenofovir disoproxil fumarate (tenofovir DF).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Tenofovir